©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Kinetic Studies of Calcium Binding to the Regulatory Site of Troponin C from Cardiac Muscle (*)

(Received for publication, June 12, 1995; and in revised form, September 27, 1995)

Wen-ji Dong (1) Steven S. Rosenfeld (2) Chien-Kao Wang (3) Albert M. Gordon (3) Herbert C. Cheung (1)(§)

From the  (1)Department of Biochemistry and Molecular Genetics and the (2)Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama 35294 and the (3)Department of Physiology and Biophysics, University of Washington, Seattle, Washington 89195

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

We have studied the kinetics of the structural transitions induced by calcium binding to the single, regulatory site of cardiac troponin C by measuring the rates of calcium-mediated fluorescence changes with a monocysteine mutant of the protein (C35S) specifically labeled at Cys-84 with the fluorescent probe 2-[4`-(iodoacetamido)anilino]naphthalene-6-sulfonic acid. At 4 °C, the binding kinetics determined in the presence of Mg was resolved into two phases with positive amplitude, which were completed in less than 100 ms. The rate of the fast phase increased linearly with [Ca] reaching a maximum of 590 s, and that of the slow phase was approximately 100 s and did not depend on Ca concentration. Dissociation of bound Ca from the regulatory site occurred with a rate of 102 s, whereas the dissociation from the two high affinity sites was about two orders of magnitude slower. These results are consistent with the following scheme for the binding of Ca to the regulatory site:

where the asterisks denote states with enhanced fluorescence. The apparent second-order rate constant for calcium binding is K(o)k(1) = 1.4 times 10^8M s. The two first-order transitions occur with observed rates of k(1) + k approx 590 s and k(2) + k approx 100 s, and the binding of Ca to the regulatory site is not a simple diffusion-controlled reaction. These transitions provide the first information on the rates of Ca-induced conformational changes involving helix movements in the regulatory domain.


INTRODUCTION

Troponin C (TnC) (^1)is the calcium-binding subunit of the three-subunit troponin complex, which, together with tropomyosin, constitutes the regulatory system in vertebrate skeletal and cardiac muscle. TnC from skeletal muscle has two classes of calcium-binding sites. The two carboxyl-terminal sites (sites 3 and 4) bind calcium with a high affinity (K approx 2 times 10^7M) and also bind magnesium competitively with a lower affinity (K approx 5 times 10^3M) (Leavis et al., 1978). These two sites appear to have a structural role and do not contribute to calcium-dependent regulation (Zot and Potter, 1987). The two amino-terminal sites (sites 1 and 2) are calcium-specific, bind calcium with a low affinity (K approx 3.2 times 10^5M) (Potter and Gergely, 1975; Leavis et al., 1978), and are the sites that regulate contraction. TnC from cardiac muscle differs from skeletal muscle TnC most significantly in the amino-terminal half, where several critical amino acid substitutions have rendered site 1 incapable of binding calcium (Van Eerd and Takahashi, 1976; Leavis and Kraft, 1978). The calcium affinities of the two classes of binding sites in cTnC (Holroyde et al., 1980) are essentially the same as the corresponding ones for skeletal muscle TnC.

The x-ray crystallographic structures of TnC from chicken (Sundaralingam et al., 1985) and turkey skeletal muscle (Herzberg and James, 1985) show that the protein has an elongated, dumbbell-like shape in which the polypeptide is folded into two globular domains at the amino- and carboxyl-terminal ends. These domains are connected by a long alpha-helix, the middle of which is exposed to the solvent. The crystal structure provides a structural basis for understanding the potential conformational changes that may occur in the regulatory, amino-terminal domain of TnC when calcium binds to sites 1 and 2 (Herzberg et al., 1986; Strynadk and James, 1989). These putative conformational changes may involve movements of helices B and C relative to helices A and D. It has been suggested that these movements expose a segment of hydrophobic residues in the amino-terminal domain, which then become available for calcium-mediated interaction with TnI. Fluorescence (Wang and Cheung, 1986; Tao et al., 1990) and thermodynamic (Wang and Cheung, 1985; Cheung et al., 1987) studies have suggested that the interaction between TnC and TnI may serve as the Ca switch for calcium-dependent regulation of contraction.

Maximum tension in fast skeletal muscle is observed in 10-13 ms after excitation and decays after an additional 40-50 ms (Close, 1965). During a cycle of contraction and relaxation, calcium must bind to the regulatory sites and induce structural changes in both TnC and the other thin filament regulatory proteins within 10-13 ms after excitation. Likewise, calcium dissociation from the regulatory sites and reversal of the calcium-induced conformational changes must occur within 40-50 ms after excitation. These physiologic constraints place limits within which reversible Ca binding to TnC and subsequent conformational changes must occur. Several groups (Iio and Kondo, 1982; Rosenfeld and Taylor, 1985a; Johnson et al., 1994) reported the kinetics of calcium binding to both classes of sites in isolated skeletal TnC and in regulatory complexes containing TnC. Calcium binding to the low affinity sites of skeletal TnC has been reported to be diffusion controlled (Johnson et al., 1994). However, given the fact that most protein conformational changes occur more slowly than this, it would be expected that the kinetics of calcium binding to the regulatory sites should be saturable. Little information is available on the kinetic mechanism of calcium binding to the regulatory site of cardiac TnC, as most of the reported information is confined to the dissociation kinetics (Robertson et al., 1981, 1982).

Cardiac TnC has two cysteine residues that can be readily alkylated by a variety of sulfhydryl-specific reagents. Mutants containing a single cysteine at either position 35 (C84S) or 84 (C35S) have been generated (Zhang et al., 1992). The calcium-induced fluorescence change of IAANS-labeled mutant cTnC(C35S) has been shown to be coincident with calcium-activated force development (Zhang et al., 1992; Kerrick et al., 1992) and ATPase activity (Kerrick et al., 1992) in skinned cardiac muscle fibers. An advantage of using IAANS-labeled mutant cTnC(C35S) to study calcium-induced structural changes is that the fluorophore is located at a single site, which simplifies interpretation of the observed fluorescence change in terms of structural transitions.

In the present work, we have studied the kinetics of calcium binding to the single regulatory site of cTnC using a monocysteine mutant labeled with IAANS at Cys-84. The observed kinetics suggest a three-step binding model. Because the IAANS probe is strategically located, the observed kinetics of the fluorescence change also provide insight into the time course of structural changes induced by calcium binding.


MATERIALS AND METHODS

Preparation of Cardiac TnC Mutants

The method of Saiki et al.(1985) was used to synthesize first strand cDNA from total RNA obtained from the left ventricle of rat heart (Chomczynski et al., 1987). The product of the first strand cDNA reaction was used in a PCR with a pair of appropriate primers. PCR products were purified using agarose gels and subsequently treated with restriction enzymes. The digested cDNAs were further purified by agarose gels and subcloned into a vector. The cDNA clone for cTnC was verified by sequence analysis and compared with the sequence of cDNA for cTnC (Parmacek and Leiden, 1989). The clone was ligated into the polylinker sites of the expression vector pET-24a(+) (Novagen). The recombinant DNA was transformed into Escherichia coli strain BL21(DE3) lysogen (Novagen) containing a gene induced by IPTG to synthesize T7 RNA polymerase, which transcribed the inert DNA in the vector. Transformed cells were grown on LB agar plates in the presence of kanamycin. Colonies were screened for inserts by either PCR or digestion of restriction enzymes. After positive clones were identified, a culture of transformed BL21(DE3) containing insert was inoculated into LB medium containing kanamycin at 37 °C. The expression of target protein was induced by adding IPTG to a final concentration of 1 mM. The induced culture was incubated for 3 more hours and harvested by centrifugation. The synthesized cTnC was purified from the induced cells according to methods provided by the supplier of the pET vector. cDNA for mutated cTnC was obtained by PCR site-directed mutagenesis (Higuchi et al., 1988). The same procedures used to clone and purify wild-type cDNA were followed for mutant cDNA, and mutant proteins were expressed and purified as described for wild-type protein. The expressed protein was purified on a DE52 column equilibrated in 6 M urea, 25 mM Tris at pH 8.0, 1 mM EGTA, and 1 mM DTT. cTnC or mutant was eluted with a salt gradient in the same buffer from 0.05 to 0.4 M KCl. The fractions containing the desired protein were pooled and dialyzed against the same buffer without urea. The dialyzed protein was adjusted to 5 mM in Ca and rechromatographed in a phenyl-Sepharose CL B4 column equilibrated in 50 mM Tris at pH 7.5, 0.3 M KCl, 1 mM DTT, and 20 mM EGTA. The purity of the eluted protein was monitored by SDS-polyacrylamide gel electrophoresis.

cTnC mutants were tested for their ability to support Ca regulation of force development using chemically skinned rabbit skeletal muscle fibers. Briefly, endogenous TnC was extracted from the fibers, and the TnC-depleted fibers were reconstituted with an exogenous TnC to be tested. Force was measured on the reconstituted fibers as a function of free Ca concentration as described previously (Martyn and Gordon, 1988).

Preparation of Labeled cTnC Mutants

Mutant cTnC(C35S) was first dialyzed against 0.1 mM DTT in a solution containing 0.2 M KCl, 30 mM Mops at pH 7.0, followed by a second dialysis in which DTT was omitted. The sulfhydryl-reduced protein was reacted with a 2-fold excess of IAANS in the presence of 6 M urea at 4 °C for 10 h. The reaction was terminated with a 3-5-fold molar excess of DTT, and the solution was exhaustively dialyzed against 6 M urea, 30 mM Mops at pH 7.0, 0.2 M KCl, and 2 mM EGTA at 4 °C to remove unreacted fluorophore and DTT. A further dialysis against the same buffer without urea was repeated three times. The concentration of the labeled protein was determined with either a turbidimetric tannin micromethod (Mejbaum-Katzenelenbogen and Dobryszycka, 1959) or the Bradford method (Bradford, 1976), and the amount of label covalently attached to the protein was determined by absorbance, using a molar extinction of 24,900 M cm at 325 nm (Johnson et al., 1980). The degree of labeling was >0.9 mol of fluorophore/mol of protein. The same procedure was used to modify the sulfhydryl group of mutant cTnC(C84S).

Fluorescence Measurements

Steady-state fluorescence measurements were carried out at 20.0 ± 0.1 °C in an SLM 8000C spectrofluorometer, with both monochromators set at a 3-nm bandwidth. All measurements were made with the ratio mode. The emission spectra were corrected for variations of the response of the detector system with wavelengths. The Ca concentration was controlled by using EGTA. Free calcium concentrations were calculated by an algorithm from Dr. A. Fabiato(1988), using known stability constants of the chelator for proton and cations.

Kinetic Measurements

Transient kinetic measurements were performed on a Hi-Tech Scientific PQ/SF-53 stopped-flow spectrometer. The dead time of the instrument was determined to be 1.8 ms. The optical system consisted of a 150-watt high pressure xenon lamp with the excitation monochromator set at 325 nm. The excitation light was directed to the observation chamber by a quartz light guide, and the emitted light was isolated at a right angle by a cut-off filter (OG 380) and detected by an EMI9798QB photomultiplier.

In a typical binding experiment, one syringe contained labeled protein in 30 mM Mops at pH 7.0, 200 mM KCl, 3.0 mM MgCl(2), and 5.0 µM EGTA. The other syringe contained the same solution but without protein, plus different levels of total Ca. After mixing, the concentration of labeled protein was usually 1 µM, and the total concentration of Ca was in the range of 0-500 µM. These conditions ensured that the two carboxyl-terminal high affinity sites were presaturated by Mg, and the single low affinity calcium-specific site remained calcium free prior to mixing. The free Ca level was controlled by the chelator. The control was quite adequate when the total Ca concentration was low. This is important because the rate data obtained at low levels of free Ca were used to calculate the bimolecular binding rate constant. At higher total Ca concentrations, there was some uncertainty in the calculated free Ca levels. As shown in Fig. 4A, the observed fast rate constant approached a limiting value at large free Ca concentration. Since it was this limiting rate constant that was important in our kinetic model, the uncertainty in free Ca concentration did not affect the analysis. For each experimental condition, 8-10 tracings were obtained. The tracings were averaged, and the resultant tracing was fitted to a sum of exponentials by a nonlinear least squares method (Bevington, 1969). To measure dissociation of bound cations, a buffer containing either EGTA or EDTA was mixed with an equal volume of protein saturated with bound cations either at sites 3 and 4 or at all three sites.


Figure 4: Plot of the two observed rate constants with positive amplitudes obtained from Ca binding experiments in the presence of Mgversus free [Ca]. The rate constants were determined at 4 °C from fluorescence transients illustrated in Fig. 3. Upper panel, the fast rate constants (f) are represented by filled circles, and the slow rate constants (s) are represented by open circles. The solid line was obtained by fitting the data to , and the recovered parameters are listed in Table 1. The slow rate constant ((s)) is not sensitive to [Ca]. Lower panel shows a plot of (f) at very low [Ca] on expanded scales. The slope of this line is 1.4 times 10^8M s.




Figure 3: A typical kinetic tracing fitted to a one-exponential and a two-exponential function. The tracing was obtained as described in Fig. 2. After mixing, [protein] = 1 µM and free [Ca] = 6.3 µM. Panel A shows the best two-exponential fit (solid curve) with two rate constants, (f) = 517 s, and (s) = 127 s; (R)^2 = 1.07. Panel B is the residual plot of the two-exponential fit. Panel C shows the residual plot for the best one-exponential fit with a rate constant of 156 s (the best fitted curve not shown); (R)^2 = 1.51. Note the differences between the two residual plots, particularly at early times.






Figure 2: Stopped-flow kinetic tracings obtained at 4 °C by mixing IAANS-labeled mutant C35S in 0.2 M KCl, 3 mM Mg, 30 mM Mops at pH 7.0, and 5 µM EGTA with an equal volume of the same buffer containing increasing concentration of free Ca. Mutant concentration after mixing was 1.0 µM. Each tracing shown in the figure was obtained from signal averaging of 8-10 separate tracings over the time interval 0-0.08 s. The full tracings from 0 to 10 s showed a second slow phase with a negative amplitude (decreasing fluorescence), which did not start until about 1 s after mixing. This slow phase is not shown here, as it was not related to Ca binding to the regulatory site. The transients with large positive amplitudes are attributed to Ca binding to the regulatory site.



Chemicals and Reagents

Restriction enzymes, T4 DNA ligase, and IPTG were obtained from Boehringer Mannheim, pfu DNA polymerase was from Stratagene Cloning Systems, and reverse transcriptase was from Invitrogen. Oligonucleotides used as primers were obtained from Integrated DNA Technologies, and radiolabeled dATP was from Amersham. Taq DNA polymerase, nucleotides, and dNTP were from Perkin Elmer and Boehringer Mannheim. Enzyme-grade urea and ammonium sulfate were purchased from Schwartz/Mann, and a standard CaCl(2) solution was obtained from Orion. IAANS was purchased from Molecular Probes. All other chemicals were of reagent grade or better.


RESULTS

Characterization of cTnC Mutants

Skinned skeletal muscle fibers depleted of endogenous TnC lose Ca regulation of force development. Calcium-activated force, however, can be restored upon reincorporation of TnC. This was the assay used to characterize cTnC mutants C35S and C84S. At pCa 4.0, the force was 92 restored, relative to intact fibers, upon reincorporation of native skeletal TnC and 86% restored upon reincorporation of wild-type cTnC. The force was 73% restored with mutant C35S and 62% restored with mutant C84S. These results indicate that the functional properties of mutant C35S are not significantly altered.

Fluorescence Properties of cTnC Mutants

Fig. 1shows fluorescence emission spectra of mutant C35S labeled with IAANS at Cys-84 in the presence of Mg and different levels of free Ca. The presence of 2 mM Mg reduced the intensity by about 10%. With increasing [Ca] over the range of pCa 6.1-4.2, the intensity progressively increased by a factor of 1.6, with a small blue spectral shift of 6 nm. A calcium titration curve of the labeled mutant cTnC is shown in the inset of Fig. 1. The half-maximum increase in fluorescence occurred at pCa 5.78 with a Hill coefficient of 1.2, corresponding to an apparent association constant of 6.1 times 10^5M. Control experiments with native cTnC yielded a Ca titration curve very similar to that shown in Fig. 1, with the half-maximum change in fluorescence at pCa 5.68, corresponding to an apparent association constant of 4.8 times 10^5M and a 1.8-fold increase in maximum fluorescence (results not shown). These results indicate that the monocysteine mutant labeled at Cys-84 has similar fluorescence properties to native cTnC labeled at both Cys-35 and Cys-84. The values of the apparent affinities, as determined by fluorescence, are also similar to those determined by equilibrium dialysis. Mutant C84S labeled with IAANS at Cys-35 showed a small increase (<30%) in fluorescence over the pCa range of 8-6.7, followed by a decrease to the 10% level with further decrease in pCa. The insensitivity of labeled mutant C84S to Ca is in agreement with a previous report (Zhang et al., 1992).


Figure 1: Fluorescence emission spectra are shown of mutant C35S labeled with IAANS at Cys-84 in the presence of Mg or different concentrations of free Ca at 20 °C, 5 µM protein in 2.0 mM EGTA, 0.2 M KCl, and 30 mM Mops at pH 7.0. Inset, Ca titration of the labeled mutant carried out in the same buffer; = 325 nm, and = 450 nm. The experimental points (filled circles) were analyzed by a nonlinear least squares procedure using the following equation:

where F and F(o) are the intensities determined at a given [Ca] and at [Ca] = 0, respectively; F(i), K, and n(i) are the intensity change, the binding constant, and the Hill coefficient of the ith site, respectively. The data were adequately fitted with one term of the equation, yielding a single binding constant corresponding to pK = 5.78 and n = 1.2.



Kinetics of Ca Binding to the Regulatory Site of Mutant C35S

The results from the Ca titration indicate that the fluorescence increase in mutant C35S labeled at Cys-84 is suitable for monitoring the kinetics of Ca binding to the regulatory site. Since our concern here was to monitor the binding kinetics of the regulatory site, it was necessary to block sites 3 and 4 by preincubation of the protein with an excess of Mg prior to mixing with Ca. Two components with opposite amplitudes were observed after mixing magnesium-saturated IAANS-labeled cTnC(C35S) with saturating calcium. The first, consisting of a 1.6-fold fluorescence enhancement, was completed in <100 ms and corresponded to calcium binding to the regulatory site, while the second, consisting of a 10% fluorescence decrease, was observed over several seconds after the first component was completed and presumably was due to calcium displacement of magnesium from the high affinity sites. Thus, these two components were temporally well separated from each other. The following discussion will focus only on the first, positive amplitude phase. Fig. 2shows kinetic tracings of this phase at increasing free Ca concentrations. At very low [Ca] (<2 µM), these tracings could be fitted with a single exponential, but above 2 µM, fitting required two exponentials. Fig. 3shows a typical tracing at [Ca] >2 µM. The monoexponential fit was only marginally adequate with a square ratio of 1.51, but the biexponential fit was considerably improved with a square ratio of 1.07. A comparison of the residual plots for the two fits also indicate an improvement of the biexponential fit over the monoexponential fit, particularly at early times.

Two observed rate constants were obtained above 2 µM calcium concentration. The fast rate constant, (f), increased with increasing Ca concentration, while the slow rate constant ((s)) appeared to be insensitive to Ca concentration. This is illustrated in Fig. 4A. The amplitude of the fast phase varied from about 60 to 30% of the total signal above 2 µM Ca. The ratio of the amplitude of the slow phase to that of the fast phase increased from less than 0.5 to a limiting value of about 2.5 with increasing [Ca], and the shape of this plot of amplitude ratio (not shown) resembled that shown in Fig. 4A for (f). The recovered limiting value of (f) was close to the dead time of the instrument, and some signal of the fast phase (about 15%) was lost at higher [Ca]. This loss was reflected in the larger uncertainty for (f) as indicated in Fig. 4A but in no way limited the analysis. The data of (f)versus [Ca] were fitted to with a maximum rate of 590 s. The initial slope of this plot (Fig. 4B) defines an apparent second-order rate constant of 1.4 times 10^8M s for calcium binding to the low affinity site.

Kinetics of Calcium Dissociation from the Amino-terminal and Carboxyl-terminal Domains

The kinetics of calcium dissociation from the low affinity site of cTnC was measured by mixing EGTA with cTnC saturated with Ca in the presence of Mg. Upon mixing, there was a fast phase with a large negative amplitude (decreasing fluorescence), which was completed in about 20 ms at 20 °C and 60 ms at 4 °C (Fig. 5), followed by a slow phase with a small positive amplitude (increasing fluorescence), which was observed over several seconds (data not shown). Similar results were obtained in the absence of Mg. Both fast and slow phases each could be fitted adequately with a single exponential function. The rate constant for the fast phase was 102 s at 4 °C and 296 s at 20 °C, and the rate constant of the slow phase was 0.65 ± 0.06 s (data not shown). To establish whether this slow phase arose from dissociation of bound Ca at the two high affinity sites in the carboxyl-terminal domain, a dissociation experiment was performed by mixing EDTA with IAANS-labeled mutant C35S, which was saturated with Mg or Ca at sites 3 and 4. The resulting kinetic tracings are shown in Fig. 6. The tracing for Mg dissociation was adequately fitted to a single exponential function, with a rate constant of 0.83 s. This experiment was also carried out under identical conditions over a short time interval. There was no evidence of a fast phase with a negative amplitude, indicating that the slow fluorescence transient in Fig. 6was due to dissociation of bound Mg from the two carboxyl-terminal domain, high affinity sites. Also shown in Fig. 6is a tracing obtained by mixing EDTA with labeled mutant C35S at pCa 7.0. At this pCa, sites 3 and 4 would be expected to be close to fully saturated with Ca, while site 2 would be Ca free. The increase in fluorescence also followed a single exponential function with a rate constant of 0.73 s. A lag phase was apparent in both dissociation tracings. This could be due to different rates of Ca/Mg dissociation from the two high affinity sites (Rosenfeld and Taylor, 1985a). The slower dissociation process might dominate the observed overall fluorescence change. Taken together, these results indicate that the dissociation of Mg or Ca from the carboxyl-terminal domain sites occurs with slow but very comparable rates. These rates were comparable to the rate (0.65 s) of the slow phase with positive amplitude observed upon mixing EGTA with labeled mutant fully saturated with Ca in the presence of Mg. Thus, Ca and Mg dissociated from the carboxyl-terminal domain sites with rates that were at least two orders of magnitude slower than dissociation of Ca from the regulatory site.


Figure 5: Kinetics of Ca dissociation from the amino-terminal domain site 2 of mutant C35S labeled with IAANS at Cys-84. Labeled mutant in 0.2 M KCl, 30 mM Mops at pH 7.0, 3 mM Mg, and 0.5 mM was mixed with an equal volume of 0.2 M KCl, 30 mM Mops at pH 7.0, and 10 mM EGTA at 4 and 20 °C. Each tracing shown is from signal averaging of 8-10 separate tracings, and the resultant tracings shown were fitted to a single exponential function. At 4 °C, rate constant = 102 s, (R)^2 = 1.11; at 20 °C, rate constant = 296 s, and (R)^2 = 1.08.




Figure 6: Kinetics of dissociation of bound Ca and bound Mg from carboxyl-terminal domain sites 3 and 4 at 4 °C. Lower tracing, a solution of 1 µM labeled protein in 0.2 M KCl, 30 mM Mops at pH 7.0, 2 mM Mg, and 20 µM EGTA was mixed with a solution of 0.2 M KCl, 30 mM Mops at pH 7.0, 20 µM EGTA, and 20 mM EDTA. 20 µM EGTA was present in both solutions to remove residual Ca. The trace was adequately fitted with a one-exponential function, with = 0.83 s, (R)^2 = 1.27. Upper tracing, a solution of 1 µM labeled protein in 0.2 M KCl, 30 mM Mops at pH 7.0, 5 µM EGTA, and pCa 7.2 was mixed with a solution of 0.2 M KCl, 30 mM Mops at pH 7.0, and 10 mM EGTA. The free [Ca] in the solution was sufficient to saturate the two high affinity sites with the regulatory site unoccupied. This tracing monitored dissociation of bound Ca at the high affinity sites and was adequately fitted with a single exponential function, = 0.73 s, (R)^2 = 1.12. The final levels of fluorescence were not the same because the protein concentrations were slightly different in the two samples.



Effect of Temperature on the Kinetics of Calcium Binding to the Regulatory Site

The experiment described for the binding of Ca to the regulatory site was repeated at several temperatures and at a saturating level of Ca. The observed rate constants of the fast and slow phases are plotted versus reciprocal temperature, as shown in Fig. 7. The activation energy for the fast phase was 7.2 ± 0.4 kJ/mol and that for the slow phase was 26 ± 3 kJ/mol.


Figure 7: Arrhenius plots of the observed rate constants obtained from experiments of Ca binding to the regulatory sites of IAANS-labeled mutant C35S as described in Fig. 2. The rate constants were obtained at [Ca] = 300 µM. The activation energy for the fast phase was 7.2 ± 0.4 kJ/mol and for the slow phase was 26 ± 3 kJ/mol. The coefficient of correlation was 0.99 for both lines.




DISCUSSION

In this paper, we have studied the kinetics of the binding of Ca to the single regulatory site of cardiac TnC. Native cTnC labeled with IAANS at both Cys-35 and Cys-84 has been extensively used to investigate the equilibrium properties of Ca binding to the single regulatory site of the isolated protein and of the protein reconstituted into myofibrils and skinned muscle fibers. Because the label is located at two different sites that are far separated in the x-ray structure of TnC, the question arises as to whether the labels at both sites sense the same events. Using bacterially produced mutants containing a single cysteine residue, recent studies have shown that the fluorescence of IAANS attached to Cys-84 in mutant C35S tracks Ca binding to the single regulatory site and produces Ca titration curves that superimpose on those for the Ca activation of ATPase and force development in skinned muscle fibers (Zhang et al., 1992). As will be further elaborated below, Cys-84 is strategically located in the amino-terminal domain, and a probe linked to this position might sense Ca-activated conformational changes involving specific helices.

To focus on the kinetics of Ca binding to the regulatory site, the binding kinetics were studied in the presence of a large excess of Mg so that the two carboxyl-terminal sites were occupied throughout the binding reaction. Since the dissociation of bound Mg is at least two orders of magnitude slower than the binding of Ca to the amino-terminal domain, this protocol enables us to follow the time course of the binding reaction directly. The kinetic transients for calcium binding to the low affinity site were biexponential at high Ca concentration. The rate constant of the fast phase ((f)) varies with increasing [Ca] in a hyperbolic manner, whereas (s) is insensitive to [Ca]. We propose a three-step mechanism to account for these kinetic data:

The initial binding in the bimolecular step is assumed to be a rapid equilibrium, which is characterized by K(o), followed by two sequential first-order transitions in which fluorescence enhancement occurs. In this scheme, if k(1) + k k(2) + k, the normalized fluorescence transient can be described by two exponential terms (Bernasconi, 1976). The rate constants from the fluorescence transient are identified with (f) and (s). The relationships of the observed rate constants to the kinetic parameters in are as follows:

and

The initial slope of a plot of (f)versus [Ca] (Fig. 4) yields an apparent second order association rate constant K(o)k(1) of 1.4 times 10^8M s. Extrapolation to [Ca] = 0 yields k = 117 s. At large [Ca], (f) = k(1) + k = 587 s. Thus, k(1) = 470 s, k = 117 s, and K(o) = 2.95 times 10^5M at 4 °C. The sum of k(2) and k is approximately 100 s. While their individual values cannot be directly extracted from the present kinetic data, they can be estimated from the experimental value of the equilibrium constant K = 3.2 times 10^5M obtained from the Ca titration at the same temperature: K = K(o)(k(1)/k)(k(2)/k). This yields k(2) = 20 s and k = 80 s. These parameters are listed in Table 1. Alternately, can be treated as described previously (Benson, 1960), and similar conclusions are obtained. The present model is the first kinetic mechanism for cardiac TnC using any preparation of the protein.

The kinetic data indicate that step 1 is thermodynamically favorable with an equilibrium constant of about 4, but step 2 is unfavorable. This is consistent with a 3.5-fold higher activation for the slow phase. Equilibrium studies have shown that the K for calcium binding to the regulatory site of a TnCbulletTnI complex is considerably larger than that for isolated TnC. If the same kinetic scheme holds for the complex, this enhanced affinity must arise from increases in the equilibrium constants of one or all steps of the model. Since step 2 is unfavorable with isolated TnC, this step may become more favorable in the binary protein complex. This possibility can be tested with either the cTnCbulletcTnI complex or reconstituted troponin.

The dissociation kinetics of Ca from the regulatory site are monoexponential at both 4 and 20 °C. Step 1 is thermodynamically favorable, but step 2 is unfavorable with an equilibrium constant of 0.25. The observed initial fluorescence change in dissociation kinetics is expected to arise from the dominant species, (CaTnC)*, with only a small contribution from (CaTnC). Thus, the observed dissociation rate constant of 102 s largely reflects k. Furthermore, the dissociation rate constant for the (CaTnC) state is predicted to be kk/(k + k(2) + k), which is approximately 50-60 s (Trybus and Taylor, 1982). It would be unlikely that a small amplitude phase in the dissociation transient occurring at 50-60 s could be resolved from the main phase, occurring at 117 s determined from the intercept in Fig. 4B.

The x-ray structure of skeletal TnC shows that in the amino-terminal domain Cys-84 is located on helix D and is surrounded by helices B and C. The calcium-saturated structural model of the amino-terminal domain suggests that Ca binding to the two amino-terminal domain sites induces movements of helices B and C relative to helices A and D, such that two EF hands are formed. These movements result in a more ``open'' conformation of the amino-terminal domain (Strynadk and James, 1989) and expose a hydrophobic patch on helix B. This exposed patch may be a site for calcium-mediated interactions with troponin I. In this model, helix D in the 4Ca state is stationary relative to the 2Ca state. A recent study of cTnC suggests similar helix movements in the amino-terminal domain when the single regulatory site is occupied (Ovsak and Taskinen, 1991). These models suggest that the observed Ca-mediated fluorescence enhancement of IAANS attached to Cys-84 on helix D may result from movements of helices B and C away from helix D. A recent study (Dong and Cheung, 1995) with native cTnC, which was selectively modified at Cys-84 with fluorescent probes, showed that the Ca-mediated enhancement of probe fluorescence was related to strong internal quenching by interactions of a dipolar nature in the apo and 2Mg states. This quenching is reduced or eliminated upon reorientation of helices B and C from helix D. This lends further support to the interpretation that the two first-order transitions that lead to fluorescence enhancement of the IAANS probe may reflect these helix movements. It is not known whether the movements actually occur in two steps, but it is unlikely that they move independently of each other because only the first fluorescence transition is Ca dependent. At a saturating level of Ca, these transitions would take about 5 ms to reach a 95% completion. This rate and the observed dissociation rate are likely overestimates of the rates that would occur in muscle. It is well known that both the time-to-peak-tension after excitation and the relaxation time can vary widely with temperature, and they are species-dependent. These time windows are generally longer in cardiac muscle than skeletal muscle, but structural transitions occurring in 5 ms in isolated cTnC may be too fast to be compatible with physiologic events. However, the Ca on- and off-rates in reconstituted troponin are expected to be slower, as the Ca dissociation rate from the regulatory site in the cTnCbulletcTnI complex is only 21 s at 20 °C (Robertson et al., 1982), a factor of 10 slower than with cTnC determined in the present work. The on-rate in reconstituted troponin or in the regulated thin filament can also be expected to be significantly slower (Robertson et al., 1981). If tension transients follow Ca transients, this anticipated reduction in the rates of reversible Ca binding should still be fast enough to support contraction.

In contrast to cardiac TnC, several studies on the kinetics of Ca binding to skeletal TnC have been reported. The early studies of Iio and Kondo (1980a, 1980b, 1982), based on tyrosine fluorescence, proposed a rapid diffusion-controlled binding step followed by conformational changes. Rosenfeld and Taylor (1985a, 1985b) investigated the binding of Ca to both classes of sites with isolated skeletal TnC and reconstituted troponin, using a fluorescently labeled preparation. A two-step binding mechanism with a second-order rate constant of 1.3 times 10^6M s was proposed for Ca binding to the high affinity sites. This value is about 100 times slower than that for Ca binding to the low affinity site in cTnC determined in the present work. Rosenfeld and Taylor (1985a, 1985b) also reported very fast Ca binding rates to the regulatory sites at low calcium concentration, and the rates at high [Ca] became too large to be measured. It could not be determined whether the rate reached a maximum, and the binding data did not establish whether the binding kinetics could be described by a two-step or a three-step model. However, the rates increased linearly with increasing [Ca] at low concentration, and an apparent second-order binding rate constant of 5 times 10^7M s was obtained. This is at least one order of magnitude larger than the corresponding rate at the high affinity sites determined using the same protein preparation. More recently, Johnson et al.(1994) reported the kinetics of Ca binding to the two regulatory sites with a tryptophan mutant of skeletal TnC(F29W). They observed monoexponential kinetic traces over a narrow range of [Ca] (0-6 µM) and assumed a simple one-step, diffusion-controlled mechanism for the binding of Ca to the two regulatory sites. Since no data were reported at higher Ca concentrations, it is not known whether the observed rate would have saturated at high [Ca]. Their apparent second-order binding rate constant is in the range of 1 times 10^8M s to 2 times 10^8M s, essentially the same as that reported here for cardiac TnC (1.4 times 10^8M s). It appears that the Ca binding rate at the regulatory sites is one to two orders of magnitude faster than that at the high affinity sites, regardless of isoform. The previous interpretation of calcium binding to the regulatory sites as a simple diffusion-controlled process (Johnson et al., 1989; 1994), however, is not consistent with the present evidence. The reporter group of the skeletal TnC mutant is Trp-29 located on helix A immediately adjacent to the amino-terminal end of the Ca-binding loop 1, whereas in the present work the reporter group is located on helix D. The different locations of the two probes may be a reason why first- order transitions arising from activator Ca-mediated movements of helices B and C were not sensed with mutant F29W.

In summary, we have used the fluorescence of an extrinsic probe linked to the single cysteine residue on helix D of a monocysteine mutant to investigate the kinetics of Ca binding to cardiac TnC. The dissociation of Ca from the regulatory site is two orders of magnitude faster than the dissociation of Ca or Mg from the two carboxyl-terminal domain sites. The kinetics of Ca binding to the regulatory sites is consistent with a three-step mechanism in which the bimolecular binding step is in rapid equilibrium and is followed by two sequential first-order transitions.


FOOTNOTES

*
This work was supported by a Postdoctoral Research Fellowship (to W.-J. D.) from the Muscular Dystrophy Association and National Institutes of Health Grants AR31239 (to H. C. C.) and NS08383 (to A. M. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed. Fax: 205-975-4621; hccheung@bmg.bhs.uab.edu.

(^1)
The abbreviations used are: TnC, troponin C; TnI, troponin I; cTnC, cardiac troponin C; DTT, dithiothreitol; IAANS, 2-[(4`-(iodoacetamido)anilino]naphthalene-6-sulfonic acid; IPTG, isopropyl-1-thio-beta-D-galactopyranoside; Mops, 3-(N-morpholino)propanesulfonic acid; PCR, polymerase chain reaction.


REFERENCES

  1. Benson, S. W. (1960) The Foundation of Chemical Kinetics , pp. 33-42, McGraw-Hill, New York
  2. Benvington, P. R. (1969) Data Reduction and Error Analysis for the Physical Sciences , McGraw-Hill, New York
  3. Bernasconi, C. F. (1976) Relaxation Kinetics , Academic Press, London
  4. Bradford, M. M. (1976) Anal. Biochem. 71, 248-254 [CrossRef]
  5. Cheung, H. C., Wang, C.-K., and Malik, N. A. (1987) Biochemistry 26, 5904-5907 [Medline] [Order article via Infotrieve]
  6. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159 [CrossRef][Medline] [Order article via Infotrieve]
  7. Close, R. (1965) J. Physiol. (Lond.) 180, 542-559
  8. Dong, W.-J., and Cheung, H. C. (1995) Biophys. J. 68, 57 (abstr.)
  9. Fabiato, A. (1988) Methods Enzymol. 313, 653-659
  10. Herzberg, O., and James, M. N. G. (1985) Nature 313, 653-659 [Medline] [Order article via Infotrieve]
  11. Herzberg, O., Moult, J., and James, M. N. G. (1986) J. Biol. Chem. 261, 2638-2644 [Abstract/Free Full Text]
  12. Higuchi, R., Krummel, B., and Saiki, R. K. (1988) Nucleic Acids Res. 16, 7351-7367 [Abstract]
  13. Holroyde, M. J., Robertson, S. P., Johnson, J. D., Solaro, R. J., and Potter, J. D. (1980) J. Biol. Chem. 255, 11688-11693 [Abstract/Free Full Text]
  14. Iio, T., and Kondo, H. (1980a) J. Biochem. (Tokyo) 88, 547-556
  15. Iio, T., and Kondo, H. (1980b) J. Biochem. (Tokyo) 88, 1087-1092
  16. Iio, T., and Kondo, H. (1982) J. Biochem. (Tokyo) 92, 1141-1149
  17. Johnson, J. D., Collins, J. H., Robertson, S. P., and Potter, J. D. (1980) J. Biol. Chem. 255, 9635-9640 [Abstract/Free Full Text]
  18. Johnson, J. D., Nakkula, R. J., Vasulka, C., and Smillie, L. (1994) J. Biol. Chem. 269, 8919-8923 [Abstract/Free Full Text]
  19. Kerrick, W. G. L., Zhang, M. Z., Chen, E., Amed, S., Potter, J. D., and Putkey, J. A. (1992) Biophys. J. 61, 156 (abstr.)
  20. Leavis, P. C., and Kraft, E. L. (1978) Arch. Biochem. Biophys. 186, 411-415 [Medline] [Order article via Infotrieve]
  21. Leavis, P. C., Rosenfeld, S. S., Gergely, J., Grabarek, Z., and Drabikowski, W. (1978) J. Biol. Chem. 253, 5452-5459 [Medline] [Order article via Infotrieve]
  22. Martyn, D. A., and Gordon, A. M. (1988) J. Muscle Res. Cell Motil. 9, 428-445 [Medline] [Order article via Infotrieve]
  23. Mejbaum-Katzenelenbogen, W., and Dobryszycka, W. M. (1959) Clin. Chim. Acta 4, 515-520
  24. Ovsak, M., and Taskinen, J. (1991) Proteins 11, 79-94 [Medline] [Order article via Infotrieve]
  25. Parmacek, M. S., and Leiden, J. M. (1989) J. Biol. Chem. 264, 13217-13225 [Abstract/Free Full Text]
  26. Potter, J. D., and Gergely, J. (1975) J. Biol. Chem. 250, 4628-4633 [Abstract]
  27. Robertson, S. P., Johnson, J. D., and Potter, J. D. (1981) Biophys. J. 43, 559-569
  28. Robertson, S. P., Johnson, J. D., Holroyde, M. J., Kranias, E. G., Potter, J. D., and Solaro, R. J. (1982) J. Biol. Chem. 257, 260-263 [Free Full Text]
  29. Rosenfeld, S. S., and Taylor, E. W. (1985a) J. Biol. Chem. 260, 242-251 [Abstract/Free Full Text]
  30. Rosenfeld, S. S., and Taylor, E. W. (1985b) J. Biol. Chem. 260, 252-261 [Abstract/Free Full Text]
  31. Saiki, R. K., Sacharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., and Arnhein, N. (1985) Science 23, 1350-1354
  32. Strynadk, N. C. J., and James, M. N. G. (1989) Annu. Rev. Biochem. 58, 591-598
  33. Sundaralingam, M., Bergston, R., Strasburg, G., Rao, S. T., Greaser, M., and Wang, B. C. (1985) Science 227, 945-948 [Medline] [Order article via Infotrieve]
  34. Tao, T., Gong, B.-J., and Leavis, P. C. (1990) Science 247, 1339-1341 [Medline] [Order article via Infotrieve]
  35. Trybus, K. M., and Taylor, E. W. (1982) Biochemistry 21, 1284-1294 [Medline] [Order article via Infotrieve]
  36. Van Eerd, J.-P., and Takahashi, K. (1976) Biochemistry 15, 1171-1180 [Medline] [Order article via Infotrieve]
  37. Wang, C.-K., and Cheung, H. C. (1985) Biophys. J. 48, 727-739 [Abstract]
  38. Wang, C.-K., and Cheung, H. C. (1986) J. Mol. Biol. 191, 509-521 [Medline] [Order article via Infotrieve]
  39. Zhang, M. Z., Putkey, J. A., Amed, S., Potter, J. D., and Kerrick, W. G. L. (1992) Biophys. J. 61, 156 (abstr.)
  40. Zot, A. S., and Potter, J. D. (1987) Annu. Rev. Biophys. Biophys. Chem. 16, 535-539 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.